A randomized, placebo-controlled trial of repeated IV antibiotic therapy for Lyme encephalopathy

Abstract

IV ceftriaxone therapy results in short-term cognitive improvement for patients with posttreatment Lyme encephalopathy, but relapse in cognition occurs after the antibiotic is discontinued. Treatment strategies that result in sustained cognitive improvement are needed.